Edition:
India

Biocryst Pharmaceuticals Files Definitive Proxy Statement Related To Pending Merger With Idera Pharmaceuticals


Monday, 2 Apr 2018 

April 2 (Reuters) - Biocryst Pharmaceuticals Inc ::BIOCRYST PHARMACEUTICALS FILES DEFINITIVE PROXY STATEMENT IN CONNECTION WITH PENDING MERGER WITH IDERA PHARMACEUTICALS.‍BIOCRYST SPECIAL MEETING OF STOCKHOLDERS SCHEDULED FOR MAY 9, 2018​.‍RECOMMEND THAT ALL CO'S STOCKHOLDERS VOTE "FOR" MERGER PROPOSAL WITH IDERA PHARMA​.‍RECOMMEND STOCKHOLDERS VOTE "FOR" BIOCRYST PROPOSALS SET FORTH IN PROXY STATEMENT, INCLUDING "FOR" MERGER PROPOSAL​. 

Company Quote

2.86
-0.04 -1.38%
20 Sep 2019